The potential role of cytokine therapy for fungal infections in patients with cancer: Is recovery from neutropenia all that is needed?

Clinical Infectious Diseases

Volumn 26, Issue 6, 1998, Pages 1270-1278

  Rodriguez Adrian, Libsen J ^a   Grazziutti, Monica L ^b   Rex, John H ^b   Anaissie, Elias J ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT CHEMOTHERAPY; BONE PAIN; CANCER PATIENT; CAPILLARY LEAK SYNDROME; CLINICAL TRIAL; DYSPNEA; FEVER; HUMAN; HYPOTENSION; IMMUNOMODULATION; LEUKOCYTE TRANSFUSION; MYALGIA; MYCOSIS; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; THROMBOCYTOPENIA; VOMITING;

EID: 0031811663     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516364     Document Type: Review

References (27)

1. Estey EH, Keating MJ, McCredie KB, Bodey GP, Freireich EJ. Causes of remission induction failure in acute myelogenous leukemia. Blood 1982;60:309-15.
2. Walter E, Bowden RA. Infections in the bone marrow transplant recipients. Infect Dis Clin North Am 1995;9:823-47.
3. Klastersky J. Empiric treatment of infection during granulocytopenia: a comprehensive approach. Infection 1989;17:59-64.
4. Anaissie EJ. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14 (suppl 1):S43-53.
5. Bodey G, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109.
6. Funai N, Shimamoto Y, Tokunaga O, Sugihara W, Yamaguchi M. Ten-year survey of incidence of infection as a cause of death in hematologic malignancies: study of 90 autopsied cases. Acta Hematol 1995;93: 25-30.
7. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-22.
8. Mattiuzzi G, Vartivarian S, Przerpiorka D, et al. Infectious complications in patients with hematological malignancies and matched unrelated donor CD3-depleted allogeneic bone marrow transplantation [abstract 1335]. In: Program and abstracts of the 36th Annual Meeting of the American Society for Hematology (Nashville). New York: American Society for Hematology, 1994.
9. Graybill JR, Alford RH. Cell-mediated immunity in cryptococcosis. Cell Immunol 1974;14:12-21.
10. Restrepo A. Immune response to Paracoccidioides brasiliensis in human and animal hosts. Curr Top Med Mycol 1987;2392-2277.
11. Ampel NM, Dois CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993;94:235-40.
12. Corry DB, Ampel NM, Christian L, Locksley RM, Galgiani JN. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis 1996;174:440-3.
13. Wu-Hsieh B, Howard DH. Modulators of immune response to fungi. In: Murphy JW, Friedman H, Bendinelli M, eds. Fungal infections and immune responses. New York: Plenum Press, 1993:213-50.
14. Casadevall A, Scharff MD. Return to the past: the case for antibodybased therapies in infectious diseases. Clin Infect Dis 1995;21: 159-61.
15. Matthews R, Burnie J. Acquired immunity to systemic candidiasis in immunodeficient mice: role of antibody to heat-shock protein. J Infect Dis 1992:166:1193-4.
16. Han Y, Cutler JE. Antibody response that protects against disseminated candidiasis. Infect Immun 1995;63:2714-9.
17. Cassone A, Boccanera M, Adriani D, Santoni G, DeBemardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun 1995;63:2619-24.
18. Bodey GP. Fungal infections complicating acute leukemia. J Chron Dis 1966;19:667-87.
19. Francis P, Walsh TJ. Approaches to management of fungal infections in cancer patients. Oncology 1992;6(5): 133-44.
20. Anaissie EJ, Bhalla SC, Karuptalos NC, et al. Immune response to Fusarium solani: in vitro and in vivo studies in murine hyalohyphomycosis [abstract G047]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996.
21. Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis 1990;162:523-8.
22. Jensen J, Warner T, Balish E. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J Infect Dis 1994;170:900-5.
23. Djeu JY, Blanchard DK, Halkias D, Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by gamma-interferon and tumor necrosis factor. J Immunol 1986;137:2980-4.
24. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982;69:617-31.
25. Lehrer RI, Cline MJ. Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer. Cancer 1971;27: 1211-7.
26. Rosner F, Valmont I, Kozinn PJ, Caroline L. Leukocyte function in patients with acute leukemia. Cancer 1970;25:835-42.
27. Zimmerli W, Zarth A, Gratwohl A, Speck B. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 1991;77:393-9.